A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.
about
Optimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOFA quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor markerRole of beta-defensin 2 and interleukin-4 receptor as stroke outcome biomarkers.The proteome buccaneers: how to unearth your treasure chest via combinatorial peptide ligand libraries.High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity.Setup for human sera MALDI profiling: the case of rhEPO treatment."The quest for biomarkers": are we on the right technical track?Combined use of a solid-phase hexapeptide ligand library with liquid chromatography and two-dimensional difference gel electrophoresis for intact plasma proteomics.A protein-centric approach for the identification of folate enzymes from the malarial parasite, Plasmodium falciparum, using OFFGEL™ solution-based isoelectric focussing and mass spectrometryAnalytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.Optimized sample treatment protocol by solid-phase peptide libraries to enrich for protein traces.The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomicsStatistical considerations of optimal study design for human plasma proteomics and biomarker discoveryEnhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity DepletionSystematic comparison of fractionation methods for in-depth analysis of plasma proteomes.Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis--an update covering the period 2008-2011Clinical proteomics and OMICS clues useful in translational medicine researchRelevant phosphoproteomic and mass spectrometry: approaches useful in clinical research.Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsProtein composition of bronchoalveolar lavage fluid and airway surface liquid from newborn pigs.Quantitative proteomics for investigating psychiatric disorders.Cancer proteomics.Mycobacterial proteomics: analysis of expressed proteomes and post-translational modifications to identify candidate virulence factors.Plasma proteome coverage is increased by unique peptide recovery from sodium deoxycholate precipitate.In-gel and OFFGEL-based proteomic approach for authentication of meat species from minced meat and meat products.Why is it important to analyze the cardiac sarcomere subproteome?Unraveling the iron deficiency responsive proteome in <i>Arabidopsis </i>shoot by iTRAQ-OFFGEL approach.Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.Peptide separation methodologies for in-depth proteomics in Arabidopsis.
P2860
Q28540277-6457A20B-E59F-41EE-9040-D0B07874A98AQ31031951-3EE6A74E-AF51-42AA-A57D-6BC6F0FE1B15Q31147078-49E02C21-BABC-46E5-8966-8B8AAC5F4015Q33600047-B7A98071-8E92-4C2A-8D19-B0A589D61217Q33900798-AF26FDEB-950D-428C-82F3-ABD3CF30064AQ33943422-7DFD4F1D-90B1-457E-A628-C895451F2233Q34116103-1A0D756D-7475-44BA-A021-2EFB8FD8EA28Q34184767-88E201D6-7F04-44DE-8FC4-231FC8029F4DQ34258524-FDB1E5C3-ACEA-4CCB-AA37-FF2026CF9B68Q34669490-567C66C5-BC79-48E2-8BDD-18700908DC13Q35001930-4ADE4EDA-6F44-40F9-97E5-382B97310DBEQ35048047-BF7D5060-AFC8-480A-9747-E89D084CBEA5Q35626023-5C918633-4908-43AE-AA94-4FEE40583933Q35873957-4A312D23-C1B0-4D88-B1FF-B31A7406BABAQ36188829-41A1B11D-CAEE-4426-8FC1-5040A52B6925Q36198969-5A32C10A-6745-4B1A-B767-B7C81F1D38D3Q36452318-B22330B9-9DD9-464A-BBC1-2EB38A3503CBQ36507644-802A5A8A-2F84-48E5-9A62-0CDB2C55911DQ36555450-23D92336-C7CD-40FB-B0DC-BC00D6971697Q36664014-916098F1-0204-46DC-9B12-69E1695CA52BQ36889137-317D4F6A-2212-4125-8041-506082562734Q37094215-16A54C73-D3BC-442D-ADC8-A2B28D648047Q37833588-F9B7C633-BDFD-4E19-B0AE-D92FE92E4279Q37994133-B03C915A-0540-4713-A9B3-6FC4D86534EEQ38325342-049A259D-5AA8-4B2F-9A77-90BEA707DF55Q40067776-3B790E83-39C1-4AE7-BA14-571DDE6D2CCFQ40111000-31CDEFB6-DE82-4EA2-8BDC-CAFD87111578Q42022510-83F7CCED-144A-426F-A9B8-8FD0CDCAFC63Q45781713-682A1F7D-69A4-4A45-A29D-1BF51F9DBE15Q47421750-9A19EEDE-5CE4-40F8-B6C6-190D90EAB47CQ50483675-D4DD57F6-24C1-4003-89D8-B8237EDFA6DB
P2860
A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@ast
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@en
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@nl
type
label
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@ast
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@en
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@nl
prefLabel
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@ast
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@en
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@nl
P2093
P2860
P356
P1476
A proteomic approach for plasm ...... ling and OFFGEL fractionation.
@en
P2093
Anthony Bourreau
Catherine Guette
Emilie Ernoult
Erick Gamelin
P2860
P304
P356
10.1155/2010/927917
P577
2009-11-01T00:00:00Z